Page last updated: 2024-08-18

4-butyrolactone and Gouty Arthritis

4-butyrolactone has been researched along with Gouty Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bing, W; Di, Y; Han, Q; Hua, L; Qi-Ming, F; Shi-He, L; Shih-Mo, Y; Ting-Ting, T; Xiu-Guo, H; Yu-Gang, W; Yu-Hua, Z	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Gouty Arthritis

Article	Year
Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells. Cell death & disease, 2016, 09-01, Volume: 7, Issue:9 Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Arthritis, Gouty; Crystallization; Culture Media, Conditioned; Cyclooxygenase 2; Cytokines; Cytoprotection; Drug Evaluation, Preclinical; Extremities; Human Umbilical Vein Endothelial Cells; Inflammasomes; Inflammation Mediators; Lipopolysaccharide Receptors; Macrophages; Male; Mice; Microfluidics; Mitogen-Activated Protein Kinases; Monosaccharides; NF-kappa B; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Uric Acid	2016

Article

Year

Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells.

Cell death & disease, 2016, 09-01, Volume: 7, Issue:9

Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Arthritis, Gouty; Crystallization; Culture Media, Conditioned; Cyclooxygenase 2; Cytokines; Cytoprotection; Drug Evaluation, Preclinical; Extremities; Human Umbilical Vein Endothelial Cells; Inflammasomes; Inflammation Mediators; Lipopolysaccharide Receptors; Macrophages; Male; Mice; Microfluidics; Mitogen-Activated Protein Kinases; Monosaccharides; NF-kappa B; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Uric Acid

2016